ELMWOOD PARK, N.J., July 2 /PRNewswire/ -- PhytoCeuticals, Inc., the highly respected developer and manufacturer of proprietary skin care formulations, who is the Fast to invent Stable Liquid L-Ascorbic Acid (Vitamin C), has terminated the agreement granting IS Clinical from Innovative Skin Care the right to exclusively market the proprietary product formulas of PhytoCeuticals, Inc. effective July 1, 2008.
The IS Clinical termination was triggered by that company's introduction of controversial new products, not created by PhytoCeuticals, Inc. that violated Dr. Mostafa M. Omar, presidents of PhytoCeuticals, Inc. medical guidelines. Dr. Omar is also the Professor of Pharmacognosy at the University of Rhode Island, School of Pharmacy commented, "It is my ethical duty as a prominent medical researcher to warn clinicians and patients that, as IS Clinical no longer has access to PhytoCeuticals, Inc. formulas and products, I cannot warrant the safety of any products sold by IS Clinical."
IS Clinical has received legal notice to remove all references to Dr. Omar and/or PhytoCeuticals, Inc., including all research citations, product claims and other related materials from all websites, advertising materials, media releases, packaging and product literature. Also IS Clinical is required to issue a clarifying press release informing clinicians and consumers, which products sold by the company prior to July 1, 2008, were actually owned and developed by PhytoCeuticals, Inc. -- a business relationship that no longer exists.
"We will take all action necessary to prohibit IS Clinical from illegal usage of our formulas and research,' added Dr. Omar. "We will protect our scientific integrity and the reputation of our unique, clinically-proven products by any and all legal means."
PhytoCeuticals, Inc. is highly respected developer and manufacturing of
proprietary skin care formulations, who is the First to invent Stable
Liquid L-Ascorbic Acid (Vitam
|SOURCE PhytoCeuticals, Inc.|
Copyright©2008 PR Newswire.
All rights reserved